BINAXNOW STREP PNEUMONIAE 22T (LFR)
Report
- Report Number
- 1221359-2024-00163
- Event Type
- Malfunction
- Date Received
- February 9, 2024
- Date of Event
- January 1, 2024
- Report Date
- February 9, 2024
- Manufacturer
- ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
- Product Code
- GTZ
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GB
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 710-100 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 710-000. B3: THE DATE PROVIDED IS AN APPROXIMATION AS THE EXACT EVENT DATE WAS NOT PROVIDED THE REQUIRED INTAKE INFORMATION TO ENABLE FURTHER INVESTIGATION, SUCH AS THE KIT'S LOT NUMBER, WAS NOT PROVIDED AND AN INVESTIGATION WAS NOT ABLE TO BE PERFORMED. NOTWITHSTANDING, COMPLAINTS AGAINST THESE TREND CODES ARE MONITORED TO IDENTIFY AND TRACK ANY OUT-OF-TREND / UNEXPECTED PERFORMANCE AT THE LOT AND PRODUCT FAMILY LEVEL. IN CONCLUSION, ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUES AS NO INFORMATION WAS PROVIDED FOR INVESTIGATION. H3 OTHER TEXT : SINGLE USE; DEVICE DISCARDED.
THE CUSTOMER REPORTED AN UNSPECIFIED NUMBER OF FALSE RESULTS WITH THE BINAXNOW STREPTOCOCCUS PNEUMONIAE ANTIGEN CARD PERFORMED ON AN UNKNOWN DATE ON AN UNKNOWN SAMPLE TYPE. NO ADDITIONAL TEST INFORMATION, INCLUDING IF THE PATIENT RESULTS WERE FALSE POSITIVE OR NEGATIVE RESULTS, WAS PROVIDED. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1338860 | BINAXNOW STREP PNEUMONIAE 22T (LFR) | ANTISERA, ALL GROUPS, STREPTOCOCCUS SPP. | GTZ | ABBOTT DIAGNOSTICS SCARBOROUGH, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |